AIEU-Startupsabout 2 hours ago
Epitome Therapeutics raises €4 million for epigenome editing
3 min read
Vienna-based Epitome Therapeutics raised €4 million in total funding to advance precision epigenome editing programmes and grow the team. The pre-seed round was co-led by XISTA Science Ventures and Caesar Ventures, with participation from Navec Venture Holding GmbH.
Level
Hype check
Tap to vote and see what everyone thinks.
